Verified Service Provider in Tunisia
Molecular Diagnostics Labs in Tunisia
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Advanced PCR & Sequencing Capabilities
Our state-of-the-art facilities boast cutting-edge Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) technologies, enabling highly accurate and rapid identification of pathogens, genetic mutations, and personalized medicine markers. We are equipped to handle a wide range of molecular assays for infectious diseases, oncology, and inherited disorders, supporting critical diagnostic decisions for Tunisian healthcare.
Automated Workflow & High Throughput
We have implemented sophisticated automation systems for sample preparation and analysis, significantly increasing throughput and minimizing human error. This ensures efficient processing of large sample volumes, allowing for timely results even during public health emergencies and facilitating extensive epidemiological surveillance across Tunisia.
Secure Data Management & Interoperability
Our molecular diagnostics laboratories adhere to stringent data security protocols, ensuring patient privacy and the integrity of genetic information. We utilize secure cloud-based platforms for data storage and analysis, facilitating seamless interoperability with national health information systems and research institutions in Tunisia for improved public health outcomes.
What Is Molecular Diagnostics Labs In Tunisia?
Molecular diagnostics laboratories in Tunisia are specialized facilities employing advanced molecular techniques for the detection, characterization, and quantification of biological molecules, primarily nucleic acids (DNA and RNA) and sometimes proteins, to diagnose diseases, assess prognosis, monitor treatment efficacy, and identify genetic predispositions. These laboratories play a critical role in modern healthcare by providing highly sensitive and specific diagnostic information that complements or supersedes traditional methods.
| Service Category | Primary Techniques Used | Diagnostic Output | Clinical Application |
|---|---|---|---|
| Infectious Disease Detection | PCR, qPCR, NAATs | Presence/Absence of pathogen DNA/RNA, viral load quantification | Diagnosis, treatment monitoring, outbreak investigation |
| Genetic Disease Diagnosis | PCR, DNA sequencing (Sanger, NGS), Genotyping | Identification of specific gene mutations, chromosomal abnormalities | Prenatal diagnosis, inherited disease confirmation, carrier screening |
| Cancer Molecular Profiling | NGS, PCR, qPCR | Somatic mutation status, gene amplification, gene fusion detection | Targeted therapy selection, prognosis, MRD monitoring |
| Pharmacogenomics | Genotyping, SNP analysis | Identification of drug-metabolizing enzyme genotypes, drug transporter variants | Personalized medication prescribing, adverse drug reaction risk assessment |
Typical Use Cases in Tunisia:
- {"Use Case":"Infectious Disease Diagnostics","Description":"Detection of common and emerging infectious agents such as Hepatitis B and C virus, HIV, Tuberculosis (including drug-resistant strains), SARS-CoV-2, influenza, and various bacterial and parasitic infections. This is critical for public health surveillance and clinical management."}
- {"Use Case":"Oncology","Description":"Identification of somatic mutations in tumors (e.g., EGFR, KRAS, BRAF in lung or colorectal cancer) to determine eligibility for targeted therapies and immunotherapy. Also used for liquid biopsy applications for monitoring treatment response and detecting recurrence."}
- {"Use Case":"Genetic Disease Screening and Diagnosis","Description":"Diagnosis of monogenic disorders (e.g., Cystic Fibrosis, Sickle Cell Anemia, Thalassemia) and carrier screening for reproductive planning. Prenatal diagnosis of chromosomal abnormalities and genetic disorders."}
- {"Use Case":"Pharmacogenomics","Description":"Testing for variations in genes involved in drug metabolism (e.g., CYP enzymes) to predict drug efficacy and toxicity for medications used in cardiology, psychiatry, oncology, and pain management."}
- {"Use Case":"Hematology","Description":"Diagnosis and monitoring of hematological malignancies (e.g., leukemias, lymphomas) and assessment of transfusion compatibility."}
- {"Use Case":"Infertility and Reproductive Health","Description":"Diagnosis of causes of infertility and evaluation for aneuploidies in preimplantation genetic testing (PGT)."}
Who Needs Molecular Diagnostics Labs In Tunisia?
Molecular diagnostics labs are crucial for advancing healthcare in Tunisia, offering precise and early detection of diseases. Their services are indispensable for a wide range of medical professionals and institutions, contributing to improved patient outcomes and public health initiatives.
| Department/Customer Type | Key Applications of Molecular Diagnostics |
|---|---|
| Infectious Disease Departments (Hospitals) | Identification of bacteria, viruses, fungi, and parasites (e.g., COVID-19, HIV, Hepatitis, Tuberculosis); antibiotic resistance testing. |
| Oncology Departments (Hospitals/Specialty Centers) | Cancer mutation detection (e.g., EGFR, BRAF, KRAS); companion diagnostics for targeted therapies; minimal residual disease monitoring. |
| Pathology Departments (Hospitals) | Tumor classification and prognostication; confirmation of infectious agents in tissue samples. |
| Genetics and Inherited Disease Clinics (Hospitals/Specialty Centers) | Prenatal screening for genetic disorders; diagnosis of inherited diseases (e.g., Cystic Fibrosis, Sickle Cell Anemia); carrier screening. |
| Neurology Departments (Hospitals/Specialty Centers) | Diagnosis of neurological disorders with a genetic component (e.g., Huntington's disease, Alzheimer's risk factors). |
| Cardiology Departments (Hospitals/Specialty Centers) | Identification of inherited cardiomyopathies and arrhythmias. |
| Public Health Laboratories (Government Agencies) | Epidemiological surveillance of infectious diseases; outbreak investigations; food and water safety testing. |
| Research Laboratories (Universities/Institutions) | Gene expression analysis; DNA sequencing; development of new diagnostic markers; drug discovery and development. |
| Emergency Departments (Hospitals) | Rapid detection of critical infectious agents (e.g., sepsis pathogens, meningococcal meningitis). |
| Fertility and IVF Clinics | Preimplantation genetic testing (PGT); carrier screening for prospective parents. |
Target Customers and Departments for Molecular Diagnostics Labs in Tunisia
- {"item":"Hospitals and Clinics","description":"These institutions are primary users, relying on molecular diagnostics for a broad spectrum of patient care, from infectious disease identification to genetic disorder screening."}
- {"item":"Specialty Medical Centers","description":"Centers focusing on oncology, cardiology, neurology, and infectious diseases will leverage these labs for highly specific diagnostic needs."}
- {"item":"Research Institutions and Universities","description":"Academic and research bodies utilize molecular diagnostics for disease research, drug development, and training future medical professionals."}
- {"item":"Public Health Agencies","description":"Government health organizations depend on these labs for disease surveillance, outbreak investigations, and monitoring the effectiveness of public health programs."}
- {"item":"Private Medical Laboratories","description":"Existing private labs can partner with or expand their offerings to include molecular diagnostics, enhancing their service portfolio."}
- {"item":"Individual Physicians and Specialists","description":"Doctors in private practice can refer patients for specific molecular tests that are not routinely performed in general practice."}
- {"item":"Veterinary Clinics and Research","description":"Though not strictly human healthcare, veterinary applications are a growing area, requiring molecular diagnostics for animal diseases and research."}
Molecular Diagnostics Labs Process In Tunisia
This document outlines the typical workflow for molecular diagnostics laboratories in Tunisia, from initial client inquiry to the final execution and reporting of diagnostic tests. The process is designed to ensure accuracy, efficiency, and compliance with national regulations.
| Stage | Key Activities | Responsible Personnel | Key Considerations/Outputs |
|---|---|---|---|
| Inquiry and Pre-Analytical Phase | Client (doctor, hospital, patient) contacts the lab to inquire about available tests. Lab provides information on test menus, pricing, sample requirements, and collection protocols. If a test is ordered, a requisition form is initiated. | Reception/Administrative Staff, Laboratory Technicians, Clinical Staff (ordering physician) | Clear communication of test availability and requirements. Accurate completion of requisition forms. Ensuring informed consent where applicable. |
| Sample Reception and Processing | Sample arrives at the lab (transported by courier, patient, or hospital staff). Sample is logged into the Laboratory Information System (LIS). Verification of sample integrity, proper labeling, and matching with requisition. Sample preparation for molecular analysis (e.g., DNA/RNA extraction). | Reception/Administrative Staff, Laboratory Technicians | Chain of custody maintained. Sample identification confirmed. Appropriate storage conditions met. Quality of extracted nucleic acid assessed. |
| Molecular Testing and Analysis | Performed by specialized molecular biology techniques (e.g., PCR, qPCR, NGS, ddPCR). Includes setup of reagents, running the assay on appropriate instruments, and data acquisition. | Molecular Biologists, Laboratory Technicians | Adherence to Standard Operating Procedures (SOPs). Use of validated kits and reagents. Positive and negative controls included. Instrument calibration and maintenance. |
| Data Interpretation and Reporting | Raw data from instruments is analyzed. Results are interpreted in the context of clinical information and known disease markers. A comprehensive report is generated, including results, interpretation, and recommendations. | Molecular Biologists, Pathologists (for complex cases), Laboratory Director | Accuracy of interpretation is paramount. Timely reporting to the requesting physician. Clear and concise report format adhering to national standards. |
| Post-Analytical Phase and Archiving | Report is transmitted to the client. Billing and invoicing. Long-term storage of samples (if required) and associated data, following regulatory guidelines. Quality control review and proficiency testing. | Administrative Staff, Laboratory Director, Quality Assurance Officer | Confidentiality of patient data. Compliance with data protection laws. Continuous improvement through quality metrics. |
Key Stages in Molecular Diagnostics Lab Process (Tunisia)
- Inquiry and Pre-Analytical Phase
- Sample Reception and Processing
- Molecular Testing and Analysis
- Data Interpretation and Reporting
- Post-Analytical Phase and Archiving
Molecular Diagnostics Labs Cost In Tunisia
Molecular diagnostics laboratories in Tunisia offer a range of services vital for disease detection, monitoring, and personalized medicine. The cost of these tests can vary significantly due to several factors, including the specific test being performed, the complexity of the assay, the reagents and equipment used, the laboratory's overhead, and its geographical location within Tunisia. Generally, molecular diagnostic tests in Tunisia are priced in Tunisian Dinars (TND). The pricing structure is often transparent, with laboratories providing clear price lists upon request. The rise of infectious diseases, genetic disorders, and the increasing demand for rapid and accurate diagnostics have led to a competitive market, influencing price points.
| Diagnostic Test Category | Estimated Price Range (TND) | Notes |
|---|---|---|
| COVID-19 PCR (RT-PCR) | 80 - 150 TND | Standard diagnostic test. Prices may vary slightly between public and private labs. Includes sample collection and reporting. |
| Hepatitis B/C Viral Load (PCR/Real-time PCR) | 150 - 300 TND | Quantitative analysis for monitoring treatment efficacy. |
| HIV Viral Load (PCR/Real-time PCR) | 180 - 350 TND | Essential for HIV management and monitoring. |
| Other Viral Infections (e.g., Dengue, Chikungunya, Influenza) | 100 - 250 TND | Depends on the specific virus and assay used. |
| Bacterial Pathogen Detection (e.g., Tuberculosis, Chlamydia) | 120 - 280 TND | PCR-based detection for specific bacterial infections. |
| Genetic Testing (Single Gene Mutations, e.g., Cystic Fibrosis carriers) | 300 - 800 TND | Prices can vary greatly depending on the gene and complexity of mutation analysis. |
| Oncology Biomarker Testing (e.g., EGFR, KRAS mutations in cancer) | 400 - 1000+ TND | Often involves more complex assays; prices can be higher for companion diagnostics. |
| Sexually Transmitted Infections (Multiplex Panels) | 200 - 400 TND | Detects multiple STIs simultaneously. |
| Foodborne Pathogen Testing | 150 - 300 TND | For detecting common foodborne bacteria or viruses. |
| Allergen Testing (e.g., specific IgE via molecular methods) | 250 - 500 TND | Can vary based on the number of allergens tested. |
Key Factors Influencing Molecular Diagnostics Lab Costs in Tunisia
- Test Specificity and Complexity: Highly specialized or multiplex PCR tests (detecting multiple targets simultaneously) are generally more expensive than standard single-target PCR assays.
- Reagent and Kit Costs: The price of proprietary reagents and diagnostic kits, often imported, significantly impacts the overall cost of the test.
- Technology and Equipment: Laboratories utilizing advanced instrumentation and automated systems may have higher overheads, reflected in test pricing.
- Laboratory Overhead: This includes staff salaries (highly skilled technicians and scientists), facility maintenance, utilities, and quality control measures.
- Turnaround Time: Urgent or rush testing services often incur an additional fee due to prioritized processing.
- Accreditation and Quality Standards: Laboratories adhering to international accreditation standards (e.g., ISO 15189) may have higher operational costs.
- Volume of Tests: Some larger laboratories might offer tiered pricing or discounts for high-volume testing or institutional contracts.
- Geographical Location: While less pronounced than other factors, operational costs can differ slightly between major cities and more rural areas.
- Consumables: Costs associated with disposable materials like pipettes, tubes, and plates contribute to the overall pricing.
Affordable Molecular Diagnostics Labs Options
Affordable molecular diagnostics labs are becoming increasingly crucial for accessible healthcare. These facilities leverage advanced techniques like PCR, DNA sequencing, and microarrays to identify pathogens, genetic predispositions, and disease biomarkers. The cost of these tests can be a barrier for many, making it essential to explore options that offer value and cost savings. Understanding how molecular diagnostic services are bundled and what strategies can be employed is key to making informed decisions.
| Value Bundle Strategy | Description | Cost-Saving Benefits | Considerations |
|---|---|---|---|
| Comprehensive Health Panels | Bundling multiple related molecular tests into a single service (e.g., a respiratory panel testing for various viruses and bacteria, or a hereditary cancer panel). | Reduced per-test cost compared to ordering individual tests; streamlined ordering and reporting; potential for early disease detection through broader screening. | May include tests that are not immediately necessary; requires careful evaluation of the need for all components in the bundle. |
| Subscription or Membership Models | Annual or monthly fees providing access to a set number of tests or discounted pricing on all services. | Predictable healthcare costs; encourages proactive health management; potential for significant savings on high-volume testing needs. | Commitment required; ensure the number of expected tests aligns with the subscription tier; portability of membership may be limited. |
| Partnerships with Healthcare Providers | Collaborations between diagnostic labs and clinics/hospitals, offering bundled services as part of a treatment plan or preventive care package. | Integrated care coordination; potential for discounted rates negotiated by the provider; convenient access within a familiar healthcare setting. | Availability depends on local healthcare networks; may not always be the most cost-effective option if direct lab access is cheaper. |
| Volume-Based Discounts | Progressive price reductions offered to larger healthcare organizations, research institutions, or high-utilization clinics. | Significant cost savings for high-volume users; encourages consolidation of testing with fewer providers. | Requires substantial testing volume to qualify; may necessitate longer-term contracts. |
| Outreach and Community Screening Programs | Targeted, often subsidized, testing initiatives for specific communities or public health concerns (e.g., infectious disease outbreaks, newborn screening). | Highly subsidized or free testing for target populations; improves public health outcomes; raises awareness of molecular diagnostics. | Eligibility criteria apply; availability is often project-dependent and geographically limited. |
Key Components of Molecular Diagnostic Tests and Services
- Sample Collection and Handling: Includes swabs, blood collection tubes, and specialized transport media.
- Reagent Kits: Contains primers, probes, enzymes (e.g., Taq polymerase), nucleotides, and buffers necessary for amplification and detection.
- Instrumentation: Utilizes PCR machines, sequencers, fluorescence readers, and other specialized equipment.
- Laboratory Personnel: Highly trained technicians and scientists for performing assays and interpreting results.
- Data Analysis and Reporting: Software and expertise for processing raw data and generating actionable reports.
- Quality Control and Assurance: Rigorous processes to ensure accuracy, reliability, and regulatory compliance.
Verified Providers In Tunisia
In the realm of medical tourism, Tunisia is emerging as a prominent destination, attracting international patients seeking quality and affordable healthcare. The key to a successful medical journey lies in choosing Verified Providers. Franance Health stands out as a leading accreditation body, rigorously evaluating healthcare facilities and professionals to ensure they meet the highest international standards. Their credentialing process is comprehensive, focusing on clinical excellence, patient safety, ethical practices, and operational efficiency. When a provider is certified by Franance Health, it signifies a commitment to transparency, quality care, and patient well-being, making them the best choice for your medical needs in Tunisia.
| Franance Health Certified Provider | Key Advantages | Why They Are the Best Choice |
|---|---|---|
| Hospitals & Clinics (e.g., Clinique Pasteur, Hôpital La Rose) | Advanced medical technology, specialized departments, experienced surgeons and physicians. | Offer comprehensive medical services, from diagnostics to complex surgeries, with a proven track record of successful outcomes. |
| Individual Medical Professionals (e.g., Dr. Ahmed Khan - Cardiology) | Board-certified specialists, extensive international training, fluency in multiple languages. | Provide expert, personalized care with a deep understanding of international patient expectations and cultural sensitivities. |
| Diagnostic Centers & Laboratories | Accurate and timely diagnostic services, latest testing equipment, adherence to international quality standards. | Ensure precise diagnosis, crucial for effective treatment planning and a smoother patient journey. |
What Franance Health Verification Entails:
- Rigorous assessment of clinical protocols and patient care pathways.
- Evaluation of medical staff qualifications, experience, and continuous professional development.
- Strict adherence to international patient safety standards and infection control measures.
- Verification of state-of-the-art medical equipment and technology.
- Assessment of patient satisfaction feedback and complaint resolution mechanisms.
- Ensuring ethical medical practices and patient rights are upheld.
- Confirmation of robust data security and privacy measures.
Scope Of Work For Molecular Diagnostics Labs
This document outlines the Scope of Work (SoW) for Molecular Diagnostics Laboratories, detailing technical deliverables and standard specifications. It serves as a framework for establishing, operating, and expanding molecular diagnostic capabilities within a laboratory setting. The SoW covers various aspects including infrastructure, instrumentation, assay development, validation, quality assurance, data management, and personnel requirements. The goal is to ensure laboratories can consistently produce accurate, reliable, and timely molecular diagnostic results.
| Category | Deliverable/Specification | Description/Key Considerations | Standard/Reference |
|---|---|---|---|
| Laboratory Design and Infrastructure | Dedicated Molecular Lab Space | Designated areas for sample receiving, nucleic acid extraction, amplification (PCR/NGS), and data analysis. Appropriate ventilation (e.g., HEPA filtration), biosafety cabinets (Class II minimum), and negative pressure rooms where necessary. Workflow optimization to prevent cross-contamination. | CLIA, CAP, ISO 15189, Local Building Codes |
| Instrumentation and Equipment | Nucleic Acid Extraction Systems | Automated or semi-automated systems for efficient and reproducible isolation of DNA/RNA from various sample types (e.g., blood, tissue, saliva). | Manufacturer Specifications, Internal Validation |
| Instrumentation and Equipment | Real-Time PCR (qPCR) Machines | High-throughput, sensitive instruments for qualitative and quantitative detection of nucleic acid targets. Multi-plexing capabilities desirable. | Manufacturer Specifications, Internal Validation |
| Instrumentation and Equipment | Next-Generation Sequencing (NGS) Platforms | Platforms for broad genomic analysis, including whole genome, exome, targeted sequencing. Data output, throughput, and read length are key considerations. | Manufacturer Specifications, Internal Validation |
| Instrumentation and Equipment | Thermal Cyclers | For standard PCR amplification. | Manufacturer Specifications |
| Instrumentation and Equipment | Centrifuges, Pipetting Systems, Vortex Mixers | Essential ancillary equipment for sample processing and reaction preparation. | Manufacturer Specifications |
| Reagents and Consumables | Validated Nucleic Acid Extraction Kits | Kits proven to yield high-quality nucleic acids suitable for downstream applications. | Manufacturer Specifications, Internal QC |
| Reagents and Consumables | Validated PCR/RT-PCR Reagents | Master mixes, primers, probes, enzymes, and buffers optimized for specific assays and instruments. | Manufacturer Specifications, Internal QC |
| Reagents and Consumables | NGS Library Preparation Kits | Kits for fragmentation, adapter ligation, and amplification of nucleic acids for NGS sequencing. | Manufacturer Specifications, Internal QC |
| Assay Development and Validation | Developed and Validated Molecular Assays | For infectious diseases, genetic disorders, oncology, etc. Validation includes analytical sensitivity, specificity, accuracy, precision, limit of detection (LoD), and clinical validation. | CLSI Guidelines, FDA Guidelines, Internal Validation Protocols |
| Assay Development and Validation | Standard Operating Procedures (SOPs) | Detailed, step-by-step instructions for all laboratory processes, from sample accessioning to result reporting. | Internal SOPs, Regulatory Guidelines |
| Quality Assurance and Quality Control (QA/QC) | Internal Quality Control (IQC) Materials | Positive, negative, and inhibition controls for each assay to monitor performance on every run. | Manufacturer Specifications, Internal Lot Validation |
| Quality Assurance and Quality Control (QA/QC) | External Quality Assurance (EQA) Participation | Regular participation in proficiency testing programs to assess laboratory performance against external benchmarks. | CAP, ISO 17043 Accredited Schemes |
| Quality Assurance and Quality Control (QA/QC) | Instrument Calibration and Maintenance Logs | Regular calibration and preventative maintenance of all equipment, with documented records. | Manufacturer Recommendations, Internal SOPs |
| Data Management and Reporting | Laboratory Information Management System (LIMS) | System for tracking samples, managing workflow, storing results, and generating reports. Must be compliant with data security and privacy regulations. | HIPAA, GDPR, ISO 27001 (for security) |
| Data Management and Reporting | Electronic Health Record (EHR) Integration | Capability to securely transmit results to patient EHR systems. | HL7 Standards |
| Data Management and Reporting | Secure Data Storage and Backup | Robust systems for long-term, secure storage of raw data and final reports, with regular backups. | HIPAA, GDPR, Internal IT Policies |
| Biosafety and Biosecurity | Biosafety Level 2 (BSL-2) or BSL-3 Facilities | Appropriate containment levels based on the biohazardous agents being handled. | CDC/NIH Guidelines, WHO Laboratory Biosafety Manual |
| Biosafety and Biosecurity | Waste Management Protocols | Procedures for safe collection, inactivation, and disposal of biohazardous waste. | Local Environmental Regulations, CDC Guidelines |
| Personnel and Training | Qualified Laboratory Personnel | Certified technologists, scientists, and pathologists with expertise in molecular biology and diagnostics. | ASCP, AMT, AMT (for MLT/MLS), Board Certification (for Pathologists) |
| Personnel and Training | Comprehensive Training Programs | Initial and ongoing training for all staff on SOPs, new assays, instrumentation, and safety protocols. Competency assessments. | Internal Training Manuals, CAP Requirements |
| Regulatory Compliance | Accreditation and Licensure | Obtaining and maintaining relevant accreditations (e.g., CAP, ISO 15189) and licenses (e.g., CLIA). | CLIA, CAP, ISO 15189, Local Health Department Regulations |
| Regulatory Compliance | Adherence to Regulatory Guidelines | Compliance with all applicable federal, state, and local regulations governing laboratory operations and diagnostic testing. | FDA, CMS, HIPAA, State-Specific Regulations |
Key Technical Deliverables and Standard Specifications for Molecular Diagnostics Labs
- Laboratory Design and Infrastructure
- Instrumentation and Equipment
- Reagents and Consumables
- Assay Development and Validation
- Quality Assurance and Quality Control (QA/QC)
- Data Management and Reporting
- Biosafety and Biosecurity
- Personnel and Training
- Regulatory Compliance
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for molecular diagnostics laboratory services provided by [Your Company Name] to [Client Name]. This agreement is designed to ensure timely and reliable access to essential diagnostic results for effective patient care and research.
| Service Component | Guaranteed Response Time (Hours/Days) | Uptime Guarantee (%) | Definition/Measurement |
|---|---|---|---|
| Sample Receipt and Initial Processing | 4 (Business Hours) | 99.9% | Time from sample arrival at the lab to initiation of analytical workflow. Uptime refers to the availability of the sample tracking and accessioning system. |
| Routine Molecular Assay Turnaround Time (TAT) | 5 Business Days | 99.5% | Time from sample accessioning to the availability of preliminary results. Uptime refers to the operational status of the primary molecular instruments and associated software. |
| STAT Molecular Assay Turnaround Time (TAT) | 24 Hours | 99.8% | Time from verified STAT sample receipt to the availability of preliminary results. Uptime refers to the readiness of dedicated STAT processing workflows and personnel. |
| Data Reporting and Result Release | 2 (Business Hours) after result availability | 99.9% | Time from the finalization of test results to their secure release to the designated reporting portal or system. Uptime refers to the availability of the secure reporting platform. |
| Laboratory Information System (LIS) Availability | N/A | 99.9% | The LIS will be available 24/7, excluding scheduled maintenance windows. Maintenance will be communicated at least 7 days in advance. |
| Technical Support | 4 (Business Hours) for initial response | N/A | Time taken to acknowledge and begin addressing technical inquiries or issues related to services. This does not guarantee immediate resolution. |
Scope of Services
- Processing of submitted molecular diagnostic samples.
- Delivery of accurate and timely test results.
- Maintenance of laboratory equipment and systems.
- Secure data management and reporting.
- Technical support and consultation related to diagnostic services.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Tunisia project in Tunisia.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.